Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population

International Journal of Cardiology
Shani BothaAletta E Schutte

Abstract

Elevated inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) are well-known risk factors for cardiovascular mortality. The less familiar marker, soluble urokinase plasminogen activator receptor (suPAR), is known to predict cancer, infections and all-cause mortality. We determined whether suPAR, CRP and IL-6 are predictive of both all-cause and cardiovascular mortality in a black population, highly burdened by cardiovascular disease and HIV infection. We included 1425 black South Africans, of which 208 died within five years after baseline data collection. EDTA plasma biomarker levels were determined, while all-cause and cardiovascular mortality were used as endpoints. At baseline suPAR, CRP and IL-6 were higher in non-survivors than in survivors (P<0.001). SuPAR (HR 1.27, 95% CI 1.09-1.48), IL-6 (HR 1.49, 95% CI 1.24-1.78) and CRP (HR 1.39, 95% CI 1.17-1.65) predicted all-cause mortality, while only suPAR (HR 1.40, 95% CI 1.04-1.87) and IL-6 (HR 1.61, 95% CI 1.10-2.35) predicted cardiovascular mortality. The prognostic value of suPAR was independent of IL-6 and CRP (P≤0.015). SuPAR predicted both all-cause and cardiovascular mortality, independent of traditional risk factors, HIV and other inflammator...Continue Reading

Associated Clinical Trials

Jul 11, 2018·Rune Børch Hasselager

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
May 21, 1999·The American Journal of Medicine·T B HarrisR Wallace
Mar 29, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K TamakoshiH Toyoshima
Mar 3, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vincenzo PanichiCiro Tetta
Apr 29, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P WittenhagenJ Eugen-Olsen
Apr 17, 2007·Morphologie : Bulletin De L'Association Des Anatomistes·J P ClarysP Van Roy
Dec 29, 2007·Cancer Treatment Reviews·Kathleen DassFazlul H Sarkar
Aug 5, 2009·Thrombosis and Haemostasis·Harald SchuettBernhard Schieffer
Dec 29, 2009·FEBS Letters·Francesco Blasi, Nicolai Sidenius
Dec 15, 2010·Hypertension·David G HarrisonCornelia M Weyand
Apr 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T MölkänenA Järvinen
Dec 6, 2011·Atherosclerosis·Bianca Fuhrman
Mar 31, 2012·International Journal of Cardiology·Stig LyngbækJørgen Jeppesen
Aug 23, 2012·International Journal of Cardiology·Stig LyngbækJørgen Jeppesen
Oct 27, 2012·Intensive Care Medicine·Ville JalkanenUNKNOWN FINNALI Study Group
Oct 15, 2013·Journal of Critical Care·Katia DonadelloJean-Louis Vincent
Feb 8, 2014·International Journal of Epidemiology·Peter Lloyd-SherlockSomnath Chatterji
Oct 25, 2014·Journal of the American Heart Association·Ralf E Harskamp, Matthew T Roe

❮ Previous
Next ❯

Citations

Feb 22, 2016·Journal of Nephrology·Francesco Reggiani, Claudio Ponticelli
Jun 30, 2015·The Canadian Journal of Cardiology·Gethin W HodgesJørgen L Jeppesen
Jan 14, 2017·Critical Reviews in Clinical Laboratory Sciences·S DesmedtM M Speeckaert
Jul 28, 2016·European Journal of Preventive Cardiology·Aletta E SchutteHugo W Huisman
Mar 24, 2017·Journal of Human Hypertension·A E SchutteH W Huisman
May 13, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Christiane DrechslerJochen Reiser
Jun 16, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Shengyuan LuoMorgan Erika Grams
Jun 7, 2019·Journal of the American Society of Nephrology : JASN·Salim S HayekJochen Reiser
Jul 16, 2021·Nature Reviews. Drug Discovery·Ilse S Daehn, Jeremy S Duffield
Oct 29, 2021·Circulation. Genomic and Precision Medicine·Nels C OlsonAlex P Reiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.